Overactive Bladder
Analyzing Access and Costs of Oral Medications for Overactive Bladder (OAB): Uncovering Disparities.
October 8, 2023
Efficacy and safety of an alternative onabotulinumtoxinA injection paradigm for refractory overactive bladder.
October 1, 2023
The Role of Sarcopenia in Overactive Bladder in Adults in the United States: Retrospective Analysis of NHANES 2011-2018.
October 1, 2023
Patient and Clinician Challenges with Anticholinergic Step Therapy in the Treatment of Overactive Bladder: A Narrative Review.
September 24, 2023
Impact of Sling at Time of Prolapse Surgery on Overactive Bladder.
September 24, 2023
Device evaluation: eCoin- implantable tibial nerve stimulator for overactive bladder.
September 17, 2023
A positive association between the prevalence of circadian syndrome and overactive bladder in United States adults.
September 3, 2023
Pelvic floor dysfunction and obesity.
September 3, 2023
Associations of Clinical and Dosimetric Parameters with Urinary Toxicities after Prostate Brachytherapy: A Long-Term Single-Institution Experience.
September 3, 2023
Assessment of prescribing practices in overactive bladder pharmacotherapy across different specialties of India: a prescription trend analysis.
August 27, 2023
Weak association between arterial hypertension and overactive bladder baseline symptoms and treatment responses.
August 27, 2023
Plain language summary of safety and symptom improvement with vibegron in people with overactive bladder: results from the EMPOWUR study.
August 20, 2023